E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 9/23/2019 in the Prospect News Convertibles Daily.

Morning Commentary: Convertible notes mostly quiet; SailPoint trades just under par

By Rebecca Melvin

New York, Sept. 23 – The top trading convertible notes in the U.S. market on Monday were the new SailPoint Technologies Holdings Inc. 0.125% notes, which priced last week and were knocking around at just below par in Monday’s session. The shares were little changed at $20.55.

But most of the active names were consistent in terms of market volume. There was not a dominant issue, and the market overall was described as “pretty quiet” by a New York-based market source.

Insulet Corp.’s older 1.375% convertibles due 2024 were trading a little below double par, with the shares of the Billerica, Mass.-based medical device maker up $2.75, or $1.8%, at $158.55 last. The new $660 million Insulet 0.375% convertibles were not seen in trade.

Alder Biopharmaceuticals Inc.’s convertibles continued to trade in a range after surging more than 20 points on an outright basis last week after it was announced that the Bothell, Wash.-based developer of therapeutic monoclonal antibodies signed a definitive agreement to be acquired by H. Lundbeck A/S.

The Alder 2.5% convertibles due 2025 traded last at 110.25, which was up from 109.5 a week ago and up from about 88 prior to that, according to Trace data. Shares on Monday were unchanged at $18.62.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.